{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:18:38Z","timestamp":1767993518622,"version":"3.49.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.mric.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:39:49Z","timestamp":1692664789000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["MR Perfusion Imaging for Gliomas"],"prefix":"10.1016","volume":"32","author":[{"given":"Jina","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Eymen","family":"Ucisik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Wintermark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinodh A.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib1","first-page":"381","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"10.1016\/j.mric.2023.07.003_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133161","article-title":"Survival Outcomes and Prognostic Factors in Glioblastoma","volume":"14","author":"Brown","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib3","first-page":"299","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA A Cancer J Clin"},{"issue":"25","key":"10.1016\/j.mric.2023.07.003_bib4","first-page":"419","article-title":"The Diagnosis and Treatment of Primary CNS Lymphoma","volume":"115","author":"von Baumgarten","year":"2018","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.26306","article-title":"Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques","volume":"49","author":"van Dijken","year":"2019","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11547-019-01128-3","article-title":"Investigating dynamic susceptibility contrast-enhanced perfusion-weighted magnetic resonance imaging in posterior fossa tumors: differences and similarities with supratentorial tumors","volume":"125","author":"Gaudino","year":"2020","journal-title":"Radiol Med"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mric.2015.09.001","article-title":"Multiparametric MR Imaging in the Assessment of Brain Tumors","volume":"24","author":"Kimura","year":"2016","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/19714009221098369","article-title":"Association of dynamic susceptibility contrast- and dynamic contrast-enhanced magnetic resonance imaging parameters with molecular marker status in lower-grade gliomas: A retrospective study","volume":"36","author":"Ahn","year":"2023","journal-title":"NeuroRadiol J"},{"issue":"2","key":"10.1016\/j.mric.2023.07.003_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/jmri.26837","article-title":"Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T","volume":"51","author":"Bell","year":"2020","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.mric.2023.07.003_bib10","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jmri.28662","article-title":"Advanced MR Techniques for Preoperative Glioma Characterization: Part 1","volume":"57","author":"Hirschler","year":"2023","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2214\/AJR.17.18003","article-title":"Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma","volume":"210","author":"Nael","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.mric.2023.07.003_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jon.12687","article-title":"Clinical Imaging for Diagnostic Challenges in the Management of Gliomas: A Review","volume":"30","author":"Bonm","year":"2020","journal-title":"J\u00a0Neuroimaging"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0284185112474916","article-title":"Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging","volume":"54","author":"Choi","year":"2013","journal-title":"Acta Radiol"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","article-title":"AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients","volume":"11","author":"Batchelor","year":"2007","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.mric.2023.07.003_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11864-018-0558-5","article-title":"The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies","volume":"19","author":"Ly","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"10.1016\/j.mric.2023.07.003_bib16","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1007\/s00330-018-5335-0","article-title":"Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis","volume":"28","author":"Suh","year":"2018","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.mric.2023.07.003_bib17","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00701-010-0774-7","article-title":"Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas","volume":"152","author":"Blasel","year":"2010","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.mric.2023.07.003_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fneur.2020.00270","article-title":"Advanced Imaging of Brain Metastases: From Augmenting Visualization and Improving Diagnosis to Evaluating Treatment Response","volume":"11","author":"Tong","year":"2020","journal-title":"Front Neurol"},{"issue":"42","key":"10.1016\/j.mric.2023.07.003_bib19","doi-asserted-by":"crossref","first-page":"69051","DOI":"10.18632\/oncotarget.12053","article-title":"The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions","volume":"7","author":"Lin","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.mric.2023.07.003_bib20","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.21873\/anticanres.12707","article-title":"Tumor-related Perfusion Changes in White Matter Adjacent to Brain Tumors: Pharmacodynamic Analysis of Dynamic 3T Magnetic Resonance Imaging","volume":"38","author":"Tupy","year":"2018","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.mric.2023.07.003_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00234-015-1524-6","article-title":"Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion","volume":"57","author":"Bauer","year":"2015","journal-title":"Neuroradiology"},{"key":"10.1016\/j.mric.2023.07.003_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.25939","article-title":"Differentiation between vasogenic edema and infiltrative tumor in patients with high-grade gliomas using texture patch-based analysis","author":"Artzi","year":"2018","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11307-021-01604-1","article-title":"Physiological MRI Biomarkers in the Differentiation Between Glioblastomas and Solitary Brain Metastases","volume":"23","author":"Heynold","year":"2021","journal-title":"Mol Imaging Biol"},{"issue":"7","key":"10.1016\/j.mric.2023.07.003_bib24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neo.2021.04.005","article-title":"Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery","volume":"23","author":"Arsiwala","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.mric.2023.07.003_bib25","doi-asserted-by":"crossref","first-page":"e979","DOI":"10.1016\/j.wneu.2021.05.026","article-title":"Differentiation of Primary Central Nervous System Lymphoma and High-Grade Glioma with Dynamic Susceptibility Contrast-Derived Metrics: Pilot Study","volume":"151","author":"Chaganti","year":"2021","journal-title":"World Neurosurg"},{"issue":"6","key":"10.1016\/j.mric.2023.07.003_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061432","article-title":"Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading","volume":"14","author":"Guida","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.mric.2023.07.003_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.wneu.2017.10.141","article-title":"Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging","volume":"112","author":"Makino","year":"2018","journal-title":"World Neurosurg"},{"issue":"12","key":"10.1016\/j.mric.2023.07.003_bib28","doi-asserted-by":"crossref","first-page":"9098","DOI":"10.1007\/s00330-021-08044-z","article-title":"Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI","volume":"31","author":"Kang","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.mric.2023.07.003_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejrad.2019.01.008","article-title":"Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging","volume":"112","author":"Xi","year":"2019","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.mric.2023.07.003_bib30","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/RCT.0000000000000622","article-title":"Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma","volume":"41","author":"Lu","year":"2017","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.mric.2023.07.003_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jmri.26602","article-title":"MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis","volume":"50","author":"Suh","year":"2019","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.mric.2023.07.003_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00234-008-0378-6","article-title":"Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI","volume":"50","author":"Haris","year":"2008","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmri.20707","article-title":"Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging","volume":"24","author":"Hakyemez","year":"2006","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"12","key":"10.1016\/j.mric.2023.07.003_bib34","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.acra.2019.12.010","article-title":"DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival","volume":"27","author":"Zhang","year":"2020","journal-title":"Acad Radiol"},{"issue":"6","key":"10.1016\/j.mric.2023.07.003_bib35","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1007\/s00330-020-06702-2","article-title":"Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas","volume":"30","author":"Wu","year":"2020","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib36","first-page":"826","article-title":"Can Dynamic Susceptibility Contrast Perfusion Imaging be Utilized to Detect Isocitrate Dehydrogenase Gene Mutation in Gliomas?","volume":"32","author":"Kilincer","year":"2022","journal-title":"Turk Neurosurg"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00062-018-0676-2","article-title":"In\u00a0Vivo Molecular Profiling of Human Glioma","volume":"29","author":"Hempel","year":"2019","journal-title":"Clin Neuroradiol"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00062-017-0590-z","article-title":"Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion","volume":"28","author":"Brendle","year":"2018","journal-title":"Clin Neuroradiol"},{"issue":"2","key":"10.1016\/j.mric.2023.07.003_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11307-022-01762-w","article-title":"3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion","volume":"25","author":"Hou","year":"2023","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.mric.2023.07.003_bib40","doi-asserted-by":"crossref","first-page":"593102","DOI":"10.3389\/fonc.2020.593102","article-title":"Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI","volume":"10","author":"Hu","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.mric.2023.07.003_bib41","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1007\/s00330-020-07090-3","article-title":"Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas","volume":"30","author":"Park","year":"2020","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/jon.12596","article-title":"MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma","volume":"29","author":"Ivanidze","year":"2019","journal-title":"J\u00a0Neuroimaging"},{"issue":"8","key":"10.1016\/j.mric.2023.07.003_bib43","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/neuonc\/noy033","article-title":"In\u00a0vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature","volume":"20","author":"Akbari","year":"2018","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.mric.2023.07.003_bib44","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3174\/ajnr.A4484","article-title":"T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status","volume":"36","author":"Arevalo-Perez","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051342","article-title":"Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions","volume":"14","author":"Stumpo","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-018-4114-2","article-title":"Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis","volume":"18","author":"Han","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.mric.2023.07.003_bib47","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00330-019-06395-2","article-title":"Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2\/FLAIR mismatch sign","volume":"30","author":"Lee","year":"2020","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tranon.2019.02.013","article-title":"Arterial Spin Labeling for Glioma Grade Discrimination: Correlations with IDH1 Genotype and 1p\/19q Status","volume":"12","author":"Wang","year":"2019","journal-title":"Translational Oncology"},{"issue":"6","key":"10.1016\/j.mric.2023.07.003_bib49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/0284185117728981","article-title":"Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI","volume":"59","author":"Lee","year":"2018","journal-title":"Acta Radiol"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.acra.2017.10.001","article-title":"Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis","volume":"25","author":"Liang","year":"2018","journal-title":"Acad Radiol"},{"key":"10.1016\/j.mric.2023.07.003_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clineuro.2018.01.003","article-title":"Preoperative Grading of Glioma Using Dynamic Susceptibility Contrast MRI: Relative Cerebral Blood Volume Analysis of Intra-tumoural and Peri-tumoural Tissue","volume":"167","author":"Soliman","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"10.1016\/j.mric.2023.07.003_bib52","doi-asserted-by":"crossref","first-page":"652.e1","DOI":"10.1016\/j.crad.2019.03.025","article-title":"Brain SPECT and perfusion MRI: do they provide complementary information about the tumour lesion and its grading?","volume":"74","author":"Daboudi","year":"2019","journal-title":"Clin Radiol"},{"issue":"6","key":"10.1016\/j.mric.2023.07.003_bib53","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3892\/etm.2017.4370","article-title":"Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery","volume":"13","author":"Ma","year":"2017","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s43055-020-00352-6","article-title":"Arterial spin labeling in the grading of brain gliomas: could it help?","volume":"51","author":"ElBeheiry","year":"2020","journal-title":"Egyptian Journal of Radiology and Nuclear Medicine"},{"issue":"9","key":"10.1016\/j.mric.2023.07.003_bib55","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.acra.2018.10.012","article-title":"Quantitative Assessment of Tumor Cell Proliferation in Brain Gliomas with Dynamic Contrast-Enhanced MRI","volume":"26","author":"Jiang","year":"2019","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib56","first-page":"5418","article-title":"Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging","volume":"14","author":"Zhao","year":"2017","journal-title":"Oncol Lett"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib57","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00330-016-4464-6","article-title":"Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging","volume":"27","author":"Kim","year":"2017","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajco.12124","article-title":"Cerebral radiation necrosis","volume":"10","author":"Na","year":"2014","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib59","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.3747\/co.26.4749","article-title":"Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis","volume":"26","author":"Donovan","year":"2019","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/197140091302600405","article-title":"Neuroimaging findings of the post-treatment effects of radiation and chemotherapy of malignant primary glial neoplasms","volume":"26","author":"Mamlouk","year":"2013","journal-title":"NeuroRadiol J"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2214\/AJR.11.7417","article-title":"Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI","volume":"198","author":"Fatterpekar","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"50","key":"10.1016\/j.mric.2023.07.003_bib62","doi-asserted-by":"crossref","first-page":"e9332","DOI":"10.1097\/MD.0000000000009332","article-title":"Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3174\/ajnr.A7501","article-title":"DSC Perfusion MRI-Derived Fractional Tumor Burden and Relative CBV Differentiate Tumor Progression and Radiation Necrosis in Brain Metastases Treated with Stereotactic Radiosurgery","volume":"43","author":"Kuo","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2018.01.009","article-title":"Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging","volume":"129","author":"Wang","year":"2018","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib65","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jmri.26900","article-title":"Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T","volume":"51","author":"Liu","year":"2020","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib66","doi-asserted-by":"crossref","first-page":"e4821","DOI":"10.1002\/nbm.4821","article-title":"Differentiation of true progression from treatment response in high-grade glioma treated with chemoradiation: a comparison study of 3D-APTW and 3D-PcASL imaging and DWI","volume":"36","author":"Hou","year":"2023","journal-title":"NMR Biomed"},{"issue":"11","key":"10.1016\/j.mric.2023.07.003_bib67","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3174\/ajnr.A6792","article-title":"Comparison of Dynamic Contrast-Enhancement Parameters between Gadobutrol and Gadoterate Meglumine in Posttreatment Glioma: A Prospective Intraindividual Study","volume":"41","author":"Park","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.acra.2011.01.018","article-title":"Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging","volume":"18","author":"Bisdas","year":"2011","journal-title":"Acad Radiol"},{"issue":"52","key":"10.1016\/j.mric.2023.07.003_bib69","doi-asserted-by":"crossref","first-page":"e23766","DOI":"10.1097\/MD.0000000000023766","article-title":"Evaluation of perfusion MRI value for tumor progression assessment after glioma radiotherapy: A systematic review and meta-analysis","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13014-019-1271-7","article-title":"DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife","volume":"14","author":"Morabito","year":"2019","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.mric.2023.07.003_bib71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas","volume":"9","author":"Brandsma","year":"2008","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.mric.2023.07.003_bib72","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2007.14.8163","article-title":"MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients","volume":"26","author":"Brandes","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib73","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jmri.26171","article-title":"Pseudoprogression of brain tumors","volume":"48","author":"Thust","year":"2018","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.mric.2023.07.003_bib74","doi-asserted-by":"crossref","first-page":"109941","DOI":"10.1016\/j.ejrad.2021.109941","article-title":"Diffusion kurtosis imaging combined with dynamic susceptibility contrast-enhanced MRI in differentiating high-grade glioma recurrence from pseudoprogression","volume":"144","author":"Shi","year":"2021","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib75","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1148\/radiol.12111472","article-title":"Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival","volume":"266","author":"Gahramanov","year":"2013","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib76","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3174\/ajnr.A6984","article-title":"Vessel Type Determined by Vessel Architectural Imaging Improves Differentiation between Early Tumor Progression and Pseudoprogression in Glioblastoma","volume":"42","author":"Kim","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.mric.2023.07.003_bib77","doi-asserted-by":"crossref","first-page":"103230","DOI":"10.1016\/j.critrevonc.2021.103230","article-title":"Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 - Radiological features and metric markers","volume":"159","author":"Le Fevre","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.mric.2023.07.003_bib78","first-page":"1061","article-title":"Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme","volume":"22","author":"Jovanovic","year":"2017","journal-title":"J\u00a0buon"},{"issue":"1","key":"10.1016\/j.mric.2023.07.003_bib79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-015-1893-z","article-title":"Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma","volume":"125","author":"Thomas","year":"2015","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.mric.2023.07.003_bib80","doi-asserted-by":"crossref","first-page":"5680522","DOI":"10.1155\/2022\/5680522","article-title":"The Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the Differentiation of Pseudoprogression and Recurrence of Intracranial Gliomas","volume":"2022","author":"Jing","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib81","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1148\/radiol.14132632","article-title":"Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging","volume":"274","author":"Yun","year":"2015","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.mric.2023.07.003_bib82","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/neuonc\/noaa066","article-title":"Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors","volume":"22","author":"Song","year":"2020","journal-title":"Neuro Oncol"},{"issue":"10","key":"10.1016\/j.mric.2023.07.003_bib83","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1212\/01.wnl.0000304121.57857.38","article-title":"Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence","volume":"70","author":"Norden","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mric.2023.07.003_bib84","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11060-016-2102-4","article-title":"Perfusion MRI as the predictive\/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis","volume":"128","author":"Choi","year":"2016","journal-title":"J\u00a0Neuro Oncol"},{"issue":"3","key":"10.1016\/j.mric.2023.07.003_bib85","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/RLU.0000000000002417","article-title":"Comparisons Between PET With 11C-Methyl-l-Methionine and Arterial Spin Labeling Perfusion Imaging in Recurrent Glioblastomas Treated With Bevacizumab","volume":"44","author":"Beppu","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"13","key":"10.1016\/j.mric.2023.07.003_bib86","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-09-0814","article-title":"A\u00a0\"vascular normalization index\" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients","volume":"69","author":"Sorensen","year":"2009","journal-title":"Cancer Res"},{"issue":"21","key":"10.1016\/j.mric.2023.07.003_bib87","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","article-title":"Response Assessment in Neuro-Oncology Clinical Trials","volume":"35","author":"Wen","year":"2017","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968923000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968923000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:46:40Z","timestamp":1761022000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968923000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1064968923000600"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2023.07.003","relation":{},"ISSN":["1064-9689"],"issn-type":[{"value":"1064-9689","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MR Perfusion Imaging for Gliomas","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}